Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease - Related Studies

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

This study is not yet open for participant recruitment.

Study NCT00606164. Last updated on January 21, 2008. Information provided by Blanchette Rockefeller Neurosciences Insitute

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Alzheimer's Disease

2	Additional conditions recognized in this trial
		Alzheimer Disease

3	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Delirium, Dementia, Amnestic, Cognitive Disorders
		Dementia
		Mental Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Tauopathies

4	Interventions listed in this trial
		Bryostatin for Injection
		Placebo

5	Additional drug interventions recognized in this trial
		Bryostatin 1

6	More general drug interventions related to this trial
		Adjuvants, Immunologic
		Antineoplastic Agents
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Blanchette Rockefeller Neurosciences Insitute